Lo que hace es que replica las clulas buenas y ataca el sistema inmunolgico a las clulas malas, que se van muriendo desde los 23 aos
After ELA treatment at 1 MIC, the percentage of bisoxonol-positive Yersinia enterocolitica and Lactobacillus plantarum cells were increased to 1.8 and 0.3%, respectively, significantly higher than that of the control cells (0.6 and 0.1%, respectively), suggesting the depolarization of the membrane
When pharmaceutical formulation experts make combination products, they need to think about co-formulation compatibility
Patients should have access to these therapies, said Dr Matthew Klebanoff, assistant professor of internal medicine at the Perelman School of Medicine who has studied prior authorization policies for GLP-1 drugs
Understanding the Synergy: Key Benefits & Research Use Cases The primary reason investigators choose a multi-peptide formulation over individual compounds comes down to cellular mechanics